Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Evidence Supports Accuracy of COPD Diagnosis Tool

Publish date:: July 10, 2019

Key clinical point: The recommended FEV₁:FVC ratio of 0.70 was effective at predicting risk of COPD severity in a large, diverse population.

Major finding: The optimal 0.71 FEV₁:FVC was not significantly different than the recommended 0.70.

Study details: The data come from a longitudinal study of 24,207 adults aged 45-102 years with COPD.

Disclosures: Lead author Dr. Bhatt disclosed a National Institutes of Health grant, consulting fees from Sunovion, and research funds from Proterix Bio. The study was supported by grants from multiple agencies of the National Institutes of Health, including the National Heart, Lung, and Blood Institute, the National Institute of Neurological Disorders and Stroke, and the National Institute on Aging.

Citation:

Bhatt SP et al. JAMA. 2019. 321:2438-47.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

DOACs look safe in elective endoscopic procedures,

Anorexia and diarrhea top list of GI symptoms in COVID-19 patients,

Must Reads in Pulmonology

E-cigarette use tied to increased COPD, asthma risk,

Obesity, hypoxia predict severity in children with COVID-19,

Telehealth finds acceptance among patients with CF, clinicians,

COVID-19 burdens follow patients after discharge,

Poverty raises depression risk in patients with cystic fibrosis,